Back to search

Peptide record

TPDB09790

Antibacterial Anticancer Antifungal standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09790
Antibacterial Anticancer Antifungal
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, and Antifungal) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GFCWNVCVYRNGVRVCHRRCN
Physicochemical Analysis
C107H165N39O26S4
ADEQILKMPST
RCV
2541.97
9.27
5
0
7
+4
0.88
-0.243
55.24
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
7240
284.82
8
Residue Composition
number
0
A
4
R
3
N
0
D
4
C
0
E
0
Q
2
G
1
H
0
I
0
L
0
K
0
M
1
F
0
P
0
S
0
T
1
W
1
Y
4
V
Amino Acid Distribution
A: 0 R: 4 N: 3 D: 0 C: 4 E: 0 Q: 0 G: 2 H: 1 I: 0 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 1 V: 4
Chemical Descriptors
21
C107H165N39O26S4
2541.97
9.27
+4
0.88
-0.243
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.5 µg/mL

Target

S. typhimurium ATCC14028

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
bacteria E. coli CVCC195 or CVCC1515 or CICC21530 serotype O157:H7 (MIC 0.25-1.0 ug/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/
Evidence 2 Activity

Activity

MIC
Antibacterial
0.25 µg/mL

Target

S. enteritidis CVCC3377

Source & Reference

dbAMP

Other

ICC21530 serotype O157:H7 (MIC 0.25-1.0 ug/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/m
Evidence 3 Activity

Activity

MIC
Antibacterial
0.25 µg/mL

Target

S. pullorum CVCC1789 or CVCC1802

Source & Reference

dbAMP

Other

/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 u
Evidence 4 Activity

Activity

MIC
Antibacterial
0.5 µg/mL

Target

S. choleraesuis CVCC503

Source & Reference

dbAMP

Other

enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or
Evidence 5 Activity

Activity

MIC
Antibacterial
2-4 µg/mL

Target

Pseudomonas aeruginosa CICC10419 or CICC21630

Source & Reference

dbAMP

Other

pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16
Evidence 6 Activity

Activity

MIC
Antibacterial
0.5-16 µg/mL

Target

Staphylococcus aureus ATCC43300 MRSA or ATCC25923

Source & Reference

dbAMP

Other

suis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC66
Evidence 7 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

S. suis CVCC606

Source & Reference

dbAMP

Other

ICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii
Evidence 8 Activity

Activity

MIC
Antibacterial
0.25 µg/mL

Target

B. subtilis ATCC6633

Source & Reference

dbAMP

Other

(MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii ATCC19119 (MIC 128 ug/ml), fungi C. albicans CGMCC2.2411 (MIC 16 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

L.ivanovii ATCC19119

Source & Reference

dbAMP

Other

C 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii ATCC19119 (MIC 128 ug/ml), fungi C. albicans CGMCC2.2411 (MIC 16 ug/ml).
Evidence 10 Activity

Activity

MIC
Antifungal
0.5 µg/mL

Target

S. typhimurium ATCC14028

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
bacteria E. coli CVCC195 or CVCC1515 or CICC21530 serotype O157:H7 (MIC 0.25-1.0 ug/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/
Evidence 11 Activity

Activity

MIC
Antifungal
0.25 µg/mL

Target

S. enteritidis CVCC3377

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ICC21530 serotype O157:H7 (MIC 0.25-1.0 ug/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/m
Evidence 12 Activity

Activity

MIC
Antifungal
0.25 µg/mL

Target

S. pullorum CVCC1789 or CVCC1802

Source & Reference

dbAMP CAFPdb Antifungipept

Other

/ml), S. typhimurium ATCC14028 (MIC 0.5 ug/ml), S. enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 u
Evidence 13 Activity

Activity

MIC
Antifungal
0.5 µg/mL

Target

S. choleraesuis CVCC503

Source & Reference

dbAMP CAFPdb Antifungipept

Other

enteritidis CVCC3377 (MIC 0.25 ug/ml), S. pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or
Evidence 14 Activity

Activity

MIC
Antifungal
2-4 µg/mL

Target

Pseudomonas aeruginosa CICC10419 or CICC21630

Source & Reference

dbAMP CAFPdb Antifungipept

Other

pullorum CVCC1789 or CVCC1802 (MIC 0.25 ug/ml), S. choleraesuis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16
Evidence 15 Activity

Activity

MIC
Antifungal
0.5-16 µg/mL

Target

Staphylococcus aureus ATCC43300 MRSA or ATCC25923

Source & Reference

dbAMP CAFPdb Antifungipept

Other

suis CVCC503 (MIC 0.5 ug/ml), P. aeruginosa CICC10419 or CICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC66
Evidence 16 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

S. suis CVCC606

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ICC21630 (MIC 2-4 ug/ml), Gram+ S. aureus ATCC43300 MRSA or ATCC25923 (MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii
Evidence 17 Activity

Activity

MIC
Antifungal
0.25 µg/mL

Target

B. subtilis ATCC6633

Source & Reference

dbAMP CAFPdb Antifungipept

Other

(MIC 0.5-16 ug/ml), S. suis CVCC606 (MIC 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii ATCC19119 (MIC 128 ug/ml), fungi C. albicans CGMCC2.2411 (MIC 16 ug/ml).
Evidence 18 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

L.ivanovii ATCC19119

Source & Reference

dbAMP CAFPdb Antifungipept

Other

C 16 ug/ml), E-faecium CMCC1.2136 (MIC >16 ug/ml), B. subtilis ATCC6633 (MIC 0.25 ug/ml), L.ivanovii ATCC19119 (MIC 128 ug/ml), fungi C. albicans CGMCC2.2411 (MIC 16 ug/ml).